Julio Pow-Sang, MD
Advertisement
Articles by Julio Pow-Sang, MD
Advertisement
Latest Updated Articles
Dr. Julio Pow-Sang on Options for Low-and Intermediate-Risk Prostate CancerPublished: August 30th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
The OncFive: Top Oncology Articles for the Week of 1/25
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5